1Ghadirian P, Lacroiax A, Perret C, et al. Breast cancer risk and nutrient intake among French Canadians in Montreal: a case-control study[J]. Breast, 1998, 7:108-113.
2Bernstein L, Ross RK. Endogenous hormones and breast cancer risk[J]. Epidemiol Rev, 1993, 15: 48-65.
3Masahiro S, Yuichiro T, Steven TO, et al,. Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer[J]. Clinical Cancer Research, 2004,10:2015-2019.
4Masahiro S, Yuichiro T, Masanori K, et al. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor and estrogen receptor β expressions[J]. Cancer Res, 2003, 63(14): 3913-3918.
5Aklillu E, Oscarson M, Hidestrand M, et al. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population[J]. Mol Pharmacol, 2002, 61(3): 586-594.
6Aklillu E, Ovrebo S, Botnen IV, et al. Characterization of common CYP1B1 variants with different capacity for benzo[α]pyrene-7, 8-Dihydrodiol epoxide formation from benzo [α] pyrene[J]. Cancer Res, 2005, 65(12):5105-5111.
7Miyoshi Y, Takahashi Y, Egawa C, et al. Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women[J]. Breast J, 2002, 8(4): 209-215.
8Hefler LA, Tempter CB, Grimm C, et al. Estrogen metabolizing gene polymo-rphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women[J]. Cancer, 2004, 101(2):264-269.
9Zheng W, Xie DW, Jin F, et al. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer[J]. Cancer, 2000, 9(2):147-150.
10Kocabas NA, Sardas S, Cholerton S, et al. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population[J].Arch Toxicol,2002,76(11): 643-649.
